In the summer of 2022, 1 in every 300 prescriptions filled was a COVID-19 antiviral, according to GoodRx data cited by NBC News. Now, antivirals account for about 1 in every 1,000 filled prescriptions.
There are a few reasons for this drop in prescriptions, NBC News reported: Many common medications are contraindications; the FDA’s approval is limited to people vulnerable to severe illness; and undesirable side effects, including a bad taste, diarrhea and nausea. The small chance for a rebound — when someone tests negative for a few days before symptoms reappear or a COVID-19 test is positive — is also discouraging uptake.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
